Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Cost-effectiveness and budget impact of obesity surgery in patients with type-2 diabetes in three European countries.

Ackroyd R, Mouiel J, Chevallier JM, Daoud F.

Obes Surg. 2006 Nov;16(11):1488-503.

PMID:
17132416
2.

Cost-effectiveness and budget impact of obesity surgery in patients with type 2 diabetes in three European countries(II).

Anselmino M, Bammer T, Fernández Cebrián JM, Daoud F, Romagnoli G, Torres A.

Obes Surg. 2009 Nov;19(11):1542-9. doi: 10.1007/s11695-009-9946-z.

PMID:
19756896
3.

[Medicoeconomic evaluation of the treatment of morbid obesity by Swedish adjustable gastric banding (SAGB)].

Chevallier JM, Daoud F, Szwarcensztein K, Volcot MF, Rupprecht MF.

Ann Chir. 2006 Jan;131(1):12-21. French.

PMID:
16364230
4.

Cost-effectiveness of insulin detemir compared to NPH insulin for type 1 and type 2 diabetes mellitus in the Canadian payer setting: modeling analysis.

Tunis SL, Minshall ME, Conner C, McCormick JI, Kapor J, Yale JF, Groleau D.

Curr Med Res Opin. 2009 May;25(5):1273-84. doi: 10.1185/03007990902869169 .

PMID:
19366302
5.

Cost-effectiveness of Roux-en-Y gastric bypass in type 2 diabetes patients.

Ikramuddin S, Klingman D, Swan T, Minshall ME.

Am J Manag Care. 2009 Sep;15(9):607-15.

6.

Gastric bypass is a cost-saving procedure: results from a comprehensive Markov model.

Faria GR, Preto JR, Costa-Maia J.

Obes Surg. 2013 Apr;23(4):460-6. doi: 10.1007/s11695-012-0816-8.

PMID:
23341033
7.

Evaluating the cost-effectiveness of laparoscopic adjustable gastric banding versus standard medical management in obese patients with type 2 diabetes in the UK.

Pollock RF, Muduma G, Valentine WJ.

Diabetes Obes Metab. 2013 Feb;15(2):121-9. doi: 10.1111/j.1463-1326.2012.01692.x.

PMID:
22882321
8.

Cost-effectiveness of sitagliptin-based treatment regimens in European patients with type 2 diabetes and haemoglobin A1c above target on metformin monotherapy.

Schwarz B, Gouveia M, Chen J, Nocea G, Jameson K, Cook J, Krishnarajah G, Alemao E, Yin D, Sintonen H.

Diabetes Obes Metab. 2008 Jun;10 Suppl 1:43-55. doi: 10.1111/j.1463-1326.2008.00886.x.

PMID:
18435673
9.

Gastrointestinal metabolic surgery for the treatment of diabetic patients: a multi-institutional international study.

Lee WJ, Hur KY, Lakadawala M, Kasama K, Wong SK, Lee YC.

J Gastrointest Surg. 2012 Jan;16(1):45-51; discussion 51-2. doi: 10.1007/s11605-011-1740-2.

PMID:
22042564
11.

Nutritional consequences of adjustable gastric banding and gastric bypass: a 1-year prospective study.

Coupaye M, Puchaux K, Bogard C, Msika S, Jouet P, Clerici C, Larger E, Ledoux S.

Obes Surg. 2009 Jan;19(1):56-65. doi: 10.1007/s11695-008-9571-2.

PMID:
18542847
12.

Effect of laparoscopic mini-gastric bypass for type 2 diabetes mellitus: comparison of BMI>35 and <35 kg/m2.

Lee WJ, Wang W, Lee YC, Huang MT, Ser KH, Chen JC.

J Gastrointest Surg. 2008 May;12(5):945-52.

PMID:
17940829
13.

Cost-effectiveness of insulin aspart versus human soluble insulin in type 2 diabetes in four European countries: subgroup analyses from the PREDICTIVE study.

Palmer JL, Goodall G, Nielsen S, Kotchie RW, Valentine WJ, Palmer AJ, Roze S.

Curr Med Res Opin. 2008 May;24(5):1417-28. doi: 10.1185/030079908X297295 .

PMID:
18400145
14.

Short-term economic impact of body weight change among patients with type 2 diabetes treated with antidiabetic agents: analysis using claims, laboratory, and medical record data.

Yu AP, Wu EQ, Birnbaum HG, Emani S, Fay M, Pohl G, Wintle M, Yang E, Oglesby A.

Curr Med Res Opin. 2007 Sep;23(9):2157-69. Review.

PMID:
17669232
15.

Direct medical costs for type 2 diabetes mellitus complications in the US commercial payer setting: a resource for economic research.

Pelletier EM, Smith PJ, Boye KS, Misurski DA, Tunis SL, Minshall ME.

Appl Health Econ Health Policy. 2008;6(2-3):103-12. doi: 10.2165/00148365-200806020-00003.

PMID:
19231904
16.
17.

Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.

Shepherd J, Jones J, Frampton GK, Tanajewski L, Turner D, Price A.

Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. Review.

18.

The cost-effectiveness of bariatric surgery.

Fang J.

Am J Gastroenterol. 2003 Sep;98(9):2097-8. Review.

PMID:
14499794
19.

Bowel habits after bariatric surgery.

Potoczna N, Harfmann S, Steffen R, Briggs R, Bieri N, Horber FF.

Obes Surg. 2008 Oct;18(10):1287-96. doi: 10.1007/s11695-008-9456-4.

PMID:
18327626
20.

Exenatide versus insulin glargine: a cost-effectiveness evaluation in patients with Type 2 diabetes in Switzerland.

Brändle M, Erny-Albrecht KM, Goodall G, Spinas GA, Streit P, Valentine WJ.

Int J Clin Pharmacol Ther. 2009 Aug;47(8):501-15.

PMID:
19640359

Supplemental Content

Support Center